YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Medtronic Pacemaker (Sigma or Kappa)


AddThis Social Bookmark Button

Medtronic Pacemaker Recall Lawyer

Keywords: Meditronic Recall Sigma Lawyer Kappa Pacemaker Lawsuit

If you have a Medtronic Kappa or Sigma pacemaker, and have experienced symptoms associated with abnormal heart rate, such as fainting or lightheadedness, your device may be defective. In June 2009,   Medtronic Inc. issued an urgent recall of certain Kappa and Sigma pacemakers because of wiring problems that could cause the devices to fail. Our Medtronic pacemaker recall lawyers are currently offering free case evaluations to victims of these defective devices.

 

Thousands of people are currently implanted with one of these Medtronic pacemakers, and there is no way to detect a problem before the device actually fails. The trauma caused by faulty Kappa and Sigma pacemakers is immeasurable. People with one of the recalled Medtronic pacemakers are at a high risk of serious injury and even death. 

 

Medtronic Inc. must be held accountable for the pain and suffering caused by its defective pacemakers. If you or someone you love was injured by one of Medtronic's faulty Kappa or Sigma pacemakers, you may be entitled to compensation. Please contact one of our Medtronic pacemaker recall lawyers right away to protect your legal rights.

 

Medtronic Kappa and Sigma Pacemaker Recall

In June 2009, the Food & Drug Administration (FDA) announced a Class I recall of several models of Kappa and Sigma pacemakers manufactured by Medtronic Inc. A Class I recall is the agency's most serious type of recall action, and is issued when there is a high probability that a defective device will cause serious injury or death.

 

The Kappa and Sigma pacemaker recall was issued because the devices may fail due to a separation of wires that connect the electronic circuit to other pacemaker components, such as the battery. Patients with malfunctioning pacemakers may experience a return of symptoms associated with abnormal heart rate, such as fainting or lightheadedness. In rare cases, pacemaker-dependent patients may experience serious injury or even death.

 

The Medtronic pacemaker recall involved roughly 21,000 devices. Most of the devices affected by the recall have been implanted in patients five years or longer.

 
The Medtronic pacemakers involved in this recall include:
 

Kappa Series 600/700/900
Sigma Series 100/200/300

 

Patients with the cited models of Kappa and Sigma pacemakers should determine if their pacemaker is part of this recall by contacting Medtronic at 1-800-505-4636 or going to the firm’s Web site. Patients who have these recalled pacemakers and those who are unsure if their pacemakers are affected should follow up with their primary care physician or cardiologist.

 

Medtronic Letter to Doctors

The Class I Medtronic pacemaker recall was preceded by a letter Medtronic Inc. issued to doctors in May 2009, alerting them to problems with some Kappa and Sigma pacemakers. The letter discussed two different wire separation issues affecting some Sigma and Kappa pacemakers. Medtronic said it had received reports of two patient deaths where it is possible, but unclear whether a wire separation issue may have been a factor.   A total of 37,000 devices may have been affected by these two issues.

 

The first issue involved an estimated 15,200 active Kappa devices and 6,100 active Sigma devices, manufactured primarily between November 2000 and November 2002. It was this issue that prompted the 2009 Class I Kappa and Sigma pacemaker recall.

 

Medtronic said it had observed 285 Kappa devices and 131 Sigma devices with this failure mechanism. Its modeling predicted failure rates of 1.1% for Kappa devices and 4.8% for Sigma over the remaining lifetime of these pacemakers due to this issue. According to the letter, there is no provocative testing that can predict which specific devices may fail, and no device programming can mitigate this issue if it occurs.

In the same letter, Medtronic updated performance and patient management recommendations of a different subset of Sigma devices with the same possible clinical presentation, previously reported in a November 2005 advisory. The 2005 advisory was related to wire separations caused by a particular cleaning solvent used in manufacturing and is not related to Kappa/Sigma wiring issue responsible for the 2009 Class I recall. There are currently an estimated 15,600 active implants from this 2005 Sigma device subset, Medtronic said.

Medtronic said that for most patients, device failure from either of these problems could result in slow heart rhythms that would cause lightheadedness or fainting, but not life-threatening complications. These patients should seek medical attention if they experience these symptoms. In a small number of patients who do need pacemakers to provide life-saving therapy at all times, however, such an event could prove fatal. Medtronic’s letter said that in these cases, doctors may want to consider replacing the pacemaker.

 

Medtronic Pacemaker Recall Lawsuit

The injuries caused by a defective Medtronic pacemaker are painful and traumatic. In many cases, patients implanted with one of these pacemakers will need to undergo additional surgery to have their device replaced. Sadly, in some instances, injuries from a recalled Kappa or Sigma pacemaker may prove fatal. 

 

Our Medtronic pacemaker recall lawyers will do everything legally possible to make sure Medtronic Inc. is held accountable for the suffering caused by its defective Kappa and Sigma pacemakers. If you would like to discuss filing a Medtronic pacemaker lawsuit, please fill out our online form or call 1-800 LAW INFO (1-800-529-4636) right away.

 
Medtronic Pacemaker (Sigma or Kappa)RSS Feed

Medtronic Says California Seeking Info on Heart Rhythm Devices

Dec 10, 2009 | Parker Waichman Alonso LLP
Medtronic Inc. is being investigated in California over its heart rhythm devices.  According to The Wall Street Journal, Medtronic recently disclosed that it had received a subpoena from the Department of Health and Human Services' Office of Inspector General in California.Medtronic reported the subpoena in a quarterly filing with the Securities and Exchange Commission (SEC) it had made on Wednesday.  The disclosure read as follows:"On September 16, 2009, the Company received a...

Medtronic Cardiac Rhythm Disease Management Site Gets FDA Warning Letter

Nov 19, 2009 | Parker Waichman Alonso LLP
Device maker giant, Medtronic, Inc., just announced that it received a warning letter from the U.S. Food & Drug Administration (FDA).According to the Twin Cities Business Journal, the letter came after an inspection of Medtronic’s Mounds View Cardiac Rhythm Disease Management site and concerned: “Corrective and preventative action and field-action timeliness, review and documentation of field action recommendations, supplier qualification and controls, and medical-device...

Grassley Putting More Heat on Spine Surgeon with Medtronic Ties

Sep 23, 2009 | Parker Waichman Alonso LLP
Senator Charles Grassley (R-Iowa) has expanded his investigation of  Dr. David Polly.  As we've reported previously, the relationship between Dr. Polly, head of spine surgery at the University of Minnesota, and  Medtronic Inc. has been under scrutiny.Grassley's probe of Dr. Polly has already revealed that he had been paid $1.2 million by Medtronic between 2003 and 2007 for consulting work. Dr. Polly had come under fire in July for not disclosing his relationship with Medtronic...

Medtronic Advisory Says Some Concerto, Virtuoso Defibrillator Batteries May Deplete Prematurely

Sep 11, 2009 | Parker Waichman Alonso LLP
Medtronic Inc. has issued an advisory for 6,300 Concerto CRT-D and Virtuoso implantable defibrillators.  According to the advisory, the batteries on these devices may be depleted sooner than normalAccording to a letter sent to physicians, the devices affected by this advisory will give a 90-day advanced warning if the batteries are nearing depletion. Medtronic maintains that the battery issue  does not compromise device functionality or affect therapy delivery.  The company said...

Lawsuits Allege Medtronic, Other Firms Illegally Marketed Surgical Ablation Products

Jul 16, 2009 | Parker Waichman Alonso LLP
Medtronic Inc., St. Jude Medical Inc., AtriCure Inc. and Boston Scientific Corp. all allegedly paid kickbacks to doctors in order to convince them to use their surgical ablation products to treat the heart-rhythm defect called atrial fibrillation, according to lawsuits recently unsealed in Texas.   According to The Wall Street Journal, the lawsuits were filed by former employees of the companies.Allegations of kickbacks by medical device makers are nothing new.  For example, in...

More Medtronic Pacemaker (Sigma or Kappa) News

Case Review Form
* Denotes required field.

Injury Topic
(Name of Drug or Device)

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Please describe your case:

Date of Incident
(mm-dd-yyyy):

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2010 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising